Abstract:General control of amino acid synthesis 5 like 1 (GCN5L1) expression is increased in nonalcoholic steatohepatitis (NASH) patients and positively relates with the severity of NASH. GCN5L1 promotes ferroptosis of hepatocytes by acetylating CypD and releases mitochondrial ROS by opening mitochondrial permeability transition pores. High mobility group box 1 recruits neutrophils and induces the generation of NETs, which promotes NASH progression. Lipid‐induced endoplasmic reticulum stress contributes to the upregulation of GCN5L1 by ATF4. Background Mitochondria play central roles in metabolic diseases including nonalcoholic steatohepatitis (NASH). However, how mitochondria regulate NASH progression remains largely unknown. Our previous findings demonstrate that mitochondrial general control of amino acid synthesis 5 like 1 (GCN5L1) is associated with mitochondrial metabolism. Nevertheless, the roles of GCN5L1 in NASH are unclear. Aims and methods The GCN5L1 expression was detected in the fatty livers of NASH patients and animals. Hepatocyte‐specific GCN5L1 deficiency or overexpression mice were used to induce NASH models by feeding with a high‐fat/high‐cholesterol or methionine‐choline deficient diet. The molecular mechanisms underlying GCN5L1‐regulated NASH were further explored and verified in mice. Results and conclusions GCN5L1 expression was increased in NASH patients. Upregulated GCN5L1 level was also illustrated in NASH mice. Mice with hepatocyte‐specific GCN5L1 conditional knockout improved the inflammatory response compared to GCN5L1flox/flox mice. However, overexpression of mitochondrial GCN5L1 augmented the inflammatory response. Mechanically, GCN5L1 acetylated CypD and enhanced its binding with ATP5B, which induced the opening of mitochondrial permeability transition pores and the release of mitochondrial ROS into the cytoplasm. The increased ROS promoted ferroptosis of hepatocytes and induced accumulation of high mobility group box 1 in the microenvironment, which recruited neutrophils and induced the generation of neutrophil extracellular traps (NETs). NETs block impaired GCN5L1‐induced NASH progression. Furthermore, the upregulation of GCN5L1 in NASH was contributed by lipid overload‐induced endoplasmic reticulum stress. Together, mitochondrial GCN5L1 has a vital function in promoting NASH progression by regulating oxidative metabolism and the hepatic inflammatory microenvironment. Thus, GCN5L1 might be a potential intervention target in NASH treatment.

Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

PGC-1 Coactivators in the Control of Energy Metabolism

PGC1 protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response.

Posttranslational Regulation of PGC-1 Alpha and Its Implication in Cancer Metabolism

PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases

Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice

PGC-1α Functions and Its Relation to Metabolic Diseases

Genome-Wide Coactivation Analysis of Pgc-1 Alpha Identifies Baf60a As A Regulator of Hepatic Lipid Metabolism

PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling

The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.

How Epigenetic Modifications Drive the Expression and Mediate the Action of PGC-1α in the Regulation of Metabolism

Mitochondrial general control of amino acid synthesis 5 like 1 promotes nonalcoholic steatohepatitis development through ferroptosis‐induced formation of neutrophil extracellular traps

Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer

The Role of PGC 1 a in Cancer Metabolism and its Therapeutic Implications

[Coactivators in Energy Metabolism: Peroxisome Proliferator-Activated Receptor-Gamma Coactivator 1 Family].

Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors